Borgida E, Kim A, Stark EN, and Miller C. Consumers and the allure of "safer" tobacco products.  Scientific and policy issues. In C. Haugtvedt C, Kardes F, and Herr P (Eds.), Handbook on Consumer Psychology. New York, NY: Lawrence Erlbaum and Associates, 2008.

Fu SS, Kodl MM, Joseph AM, Hatsukami DK, Johnson EO, Breslau N, Wu B, and Bierut L. Racial/ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers aged 25-44. Cancer Epidemiology, Biomarkers and Prevention 2008;17(7):1640-1647.

Hanson K, Zylla E, Allen, S., Li, Z., & Hatsukami, D. Cigarette reduction: an intervention for adolescent smokers. Drug and Alcohol Dependence 2008;95(1-2):164-168.

Harris AC, Pentel PR, LeSage MG. Compensatory nicotine self-administration in rats during reduced access to nicotine: an animal model of smoking reduction. Experimental and Clinical Psychopharmacology 2008;16(1):86-97.

Hatsukami D, Ebbert JO, Edmonds A, et al. Smokeless tobacco reduction: Preliminary study of tobacco-free snuff versus no snuff. Nicotine & Tobacco Research 2008;10(1):77-85.

Hatsukami D, Ebbert JO, Feuer RM, Stepanov I, Hecht S. Changing smokeless tobacco products. New tobacco-delivery systems. American Journal of Preventive Medicine 2008;33(6 Suppl):S368-S378.

Hatsukami D, Stead LF, Gupta P. Tobacco addiction: Diagnosis and treatment. The Lancet 2008;371(9629):2027-2038.

Hecht SS, Carmella SG, Edmonds A, et al. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco. Tob Control, 17(2):128-131.

Hecht SS, Carmella SG, Stepanov I, Jensen J, et al. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Cancer Epidemiology, Biomarkers and Prevention 2008;17(3):732-735.

Hertsgaard LA, Hanson K, Hecht SS, et al. Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokers. Cancer Epidemiology, Biomarkers and Prevention 2008;17(12):3337-3343.

Hoeppner BB, Goodwin MS, Velicer FV, et al. Detecting longitudinal patterns of daily smoking following drastic cigarette reduction. Addictive Behaviors 2008;33(5):623-639.

Joseph AM, Hecht SS, Murphy SE, et al. Smoking reduction fails to improve clinical and biological biomarkers of cardiac disease: a randomized controlled trial. Nicotine & Tobacco Research 2008;10(3):471-481.

Le Marchand L, Derby KS, Murphy SE, et al. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Research 2008;68(22):9137-9140.

Mooney ME, Li ZZ, Murphy SE, et al. Stability of the nicotine metabolite ratio in ad libitum and reducing smokers. Cancer Epidemiology, Biomarkers and Prevention 2008;17(6):1396-1400.

Roiko SA, Harris AC, Keyler DE, et al. Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats. Journal of Pharmacology and Experimental Therapeutics 2008;325(3):985-993.

Stark E, Kim A, Miller C, Borgida E. Effects of including a graphic warning label in advertisements for reduced exposure tobacco products: Implications for persuasion and policy. Journal of Applied Social Psychology 2008;38(2):281-293.

Stark E, Borgida E, Kim A, Pickens B. Understanding public attitudes toward tobacco harm reduction: The role of attitude structure. Journal of Applied Social Psychology 2008;28(10):2615-2635.